Simvastatin for Spinal Cord Injury

"There are preliminary studies indicating the safety of simvastatin, thus granting it a score of 2 on our scale. However, there is yet to be any data confirming its efficacy."

"The parameters for enrollment dictate that individuals must be between 18 and 60 years of age to qualify."

"Simvastatin is a popular treatment for high cholesterol, as well as diabetes mellitus, prevention of cardiovascular disease, and hypercholesterolemia."

"Unfortunately, this trial is not currently recruiting at the moment. The original listing was posted on July 1st 2017 with a final update occurring in December 2021. If you're searching for other studies related to osteoporosis, there are 483 trials still actively looking for participants and 37 clinical trials seeking individuals taking Simvastatin medication."

"The initial research into Simvastatin began in 2005, with Merck Sharp & Dohme LLC sponsoring the first clinical trial. Following this 80-person study, Phase 4 drug approval was granted for Simvastatin and today there are 37 active trials taking place across 239 cities and 31 countries."

"This clinical trial is not presently seeking participants. The protocol was initially published on July 1st 2017, with the last update occurring December 6th 2021. If you are searching for an alternate study, there are 483 trials recruiting individuals who have osteoporosis and 37 studies accepting patients taking Simvastatin."

"This research project requires 76 individuals, aged 18-60, with a diagnosis of osteoporosis. Furthermore, participants must utilize wheelchairs as their primary means of locomotion and have sustained an acute spinal cord injury (AIS A-C) within the past three months. Lastly, they need to be able to understand directions in order to qualify for this study."

"At this time, 37 studies involving simvastatin are in progress. Of these research initiatives, 7 have progressed to the third phase of clinical trials. Although most experiments with Simvastatin are being conducted in Pontyclun, Wales; a total of 480 sites across multiple countries are running such investigations."